Improved understanding of the interrelated nature of cardiovascular, kidney and metabolic (CKM) health, the development of novel risk prediction equations, and the availability of powerful new therapies provide an opportunity to change the course of CKM health. Achieving such change at a population level will require additional advances to deliver equitable interdisciplinary care.
This is a preview of subscription content, log in via an institution to check access.
References
Ndumele, C. E. et al. Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association. Circulation 148, 1606–1635 (2023).
Khan, S. S. et al. Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating cardiovascular-kidney-metabolic health: a scientific statement from the American Heart Association. Circulation 148, 1982–2004 (2023).
Khan, S. S. et al. Development and validation of the American Heart Association Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) equations. Circulation (2023).
Bakris, G. L. et al. Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes. N. Engl. J. Med. 383, 2219–2229 (2020).
Brosius, F. C. et al. Transforming the care of patients with diabetic kidney disease. Clin. J. Am. Soc. Nephrol. 16, 1590–1600 (2021).
Kosiborod, M. N. et al. Semaglutide in patients with heart failure with preserved ejection fraction and obesity. N. Engl. J. Med. 389, 1069–1084 (2023).
Zinman, B. et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N. Engl. J. Med. 373, 2117–2128 (2015).
Vyas, D. A., Eisenstein, L. G. & Jones, D. S. Hidden in plain sight - reconsidering the use of race correction in clinical algorithms. N. Engl. J. Med. 383, 874–882 (2020).
Waters, H. & Graf, M. America’s Obesity Crisis. The Health and Economic Costs of Excess Weight (Milken Institute, 2018).
AHA. Get With The Guidelines. heart.org, https://www.heart.org/en/professional/quality-improvement/get-with-the-guidelines (2024).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Related links
PREVENT online calculator: https://professional.heart.org/en/guidelines-and-statements/prevent-calculator
Rights and permissions
About this article
Cite this article
Quaggin, S.E., Magod, B. A united vision for cardiovascular–kidney–metabolic health. Nat Rev Nephrol 20, 273–274 (2024). https://doi.org/10.1038/s41581-024-00812-6
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41581-024-00812-6
- Springer Nature Limited